Pharmaceutical Executive
May 22, 2014
Column
0
0
Despite provisions in the Affordable Care Act that require qualified health plans to cover 'basic' benefits, access to prescription drugs may be limited by high out-of-pocket costs and tight pharmacy management strategies.
May 15, 2014
Column
0
0
MNCs can learn a lot from generic companies in their strategic approaches to emerging markets.
May 06, 2014
Column
0
0
We check back with previous Pharm Exec Brand of the Year winners to see how things are going.
May 06, 2014
Features
0
0
Driven by a rising GDP and calmer political and financial waters over the past decade, Africa's nascent healthcare sector is poised for a fresh surge in growth.
May 01, 2014
From the Editor
0
0
Recent deal making signals that the rehabilitation of big Pharma has entered a new phase aligned around a new strategic thesis, writes Pharm Exec Editor-in-Chief William Looney.
May 01, 2014
Features
0
0
Pharm Exec's Brand of the Year recipients for 2014 are multiple sclerosis treatment Copaxone and KORLYM for diseases driven by excess production of the metabolic hormone, cortisol. We profile the journey of both drugs.
May 01, 2014
Column
0
0
Digital technology has changed the risk relationship between brands, HCPs, and patients – it's vital to get that technology working right the first time.